G7 Therapeutics
G7 Therapeutics is focused on stabilizing GPCRs for the discovery of novel medicines.
Get premium to view all results
| Date | Investors | Amount | Round |
|---|---|---|---|
| investor | €0.0 | round | |
| investor investor investor investor | €0.0 | round | |
| investor | €0.0 | round | |
CHF12.0m Valuation: CHF12.0m | Acquisition | ||
| Total Funding | 000k | ||
University of Zürich(exited)
EQT Life Sciences(exited)
Inkef(exited)
Gimv(exited)
Wellington Partners(exited)
RVO Innovation Credit(exited)
Related Content
Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads